Carfilzomib, lenalidomide, and dexamethasone in patients with relapsed multiple myeloma categorised by age: secondary analysis from the phase 3 ASPIRE study

Meletios A. Dimopoulos, A. Keith Stewart, Tamás Masszi, Ivan Špička, Albert Oriol, Roman Hájek, Laura Rosiñol, David Siegel, Georgi G. Mihaylov, Vesselina Goranova-Marinova, Péter Rajnics, Aleksandr Suvorov, Ruben Niesvizky, Andrzej Jakubowiak, Jesus San-Miguel, Heinz Ludwig, Antonio Palumbo, Mihaela Obreja, Sanjay Aggarwal, Philippe Moreau
  • British Journal of Haematology, February 2017, Wiley
  • DOI: 10.1111/bjh.14549
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: TAMAS DR MASSZI and Dr Albert Oriol